Truist Financial Maintains Gilead Sciences(GILD.US) With Hold Rating
Gilead Sciences (GILD) Gets a Hold From Truist Financial
Gilead Gets Key European Backing for Liver-Disease Treatment
Gilead Sciences Says Committee For Medicinal Products For Human Use Of European Medicines Agency Recommends Seladelpar For Treatment Of Primary Biliary Cholangitis In Combination With Ursodeoxycholic Acid (UDCA) In Adults With Inadequate Response To...
Express News | Gilead: Final European Commission Decision Is Anticipated in Q1 of 2025
Express News | Gilead’s Seladelpar Receives Positive Chmp Opinion for Primary Biliary Cholangitis
